BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nollet M, Leman S. Role of Orexin in the Pathophysiology of Depression: Potential for Pharmacological Intervention. CNS Drugs 2013;27:411-22. [DOI: 10.1007/s40263-013-0064-z] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 5.9] [Reference Citation Analysis]
Number Citing Articles
1 Lu J, Zhao J, Balesar R, Fronczek R, Zhu QB, Wu XY, Hu SH, Bao AM, Swaab DF. Sexually Dimorphic Changes of Hypocretin (Orexin) in Depression. EBioMedicine 2017;18:311-9. [PMID: 28377228 DOI: 10.1016/j.ebiom.2017.03.043] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 6.2] [Reference Citation Analysis]
2 Alijanpour S, Khakpai F, Ebrahimi-ghiri M, Zarrindast M. Co-administration of the low dose of orexin and nitrergic antagonists induces an antidepressant-like effect in mice. Biomedicine & Pharmacotherapy 2019;109:589-94. [DOI: 10.1016/j.biopha.2018.10.033] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
3 Liu RJ, Duman C, Kato T, Hare B, Lopresto D, Bang E, Burgdorf J, Moskal J, Taylor J, Aghajanian G, Duman RS. GLYX-13 Produces Rapid Antidepressant Responses with Key Synaptic and Behavioral Effects Distinct from Ketamine. Neuropsychopharmacology 2017;42:1231-42. [PMID: 27634355 DOI: 10.1038/npp.2016.202] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 9.5] [Reference Citation Analysis]
4 Nephew BC, Huang W, Poirier GL, Payne L, King JA. Altered neural connectivity in adult female rats exposed to early life social stress. Behav Brain Res 2017;316:225-33. [PMID: 27594665 DOI: 10.1016/j.bbr.2016.08.051] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
5 Tsuneki H, Wada T, Sasaoka T. Chronopathophysiological implications of orexin in sleep disturbances and lifestyle-related disorders. Pharmacology & Therapeutics 2018;186:25-44. [DOI: 10.1016/j.pharmthera.2017.12.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
6 Li H, Lu J, Li S, Huang B, Shi G, Mou T, Xu Y. Increased Hypocretin (Orexin) Plasma Level in Depression, Bipolar Disorder Patients. Front Psychiatry 2021;12:676336. [PMID: 34135789 DOI: 10.3389/fpsyt.2021.676336] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Lu J, Li S, Li H, Mou T, Zhou L, Huang B, Huang M, Xu Y. Changes In Plasma NPY, IL-1β And Hypocretin In People Who Died By Suicide. Neuropsychiatr Dis Treat 2019;15:2893-900. [PMID: 31632037 DOI: 10.2147/NDT.S219962] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Urrila AS, Paunio T, Palomäki E, Marttunen M. Sleep in adolescent depression: physiological perspectives. Acta Physiol (Oxf) 2015;213:758-77. [PMID: 25561272 DOI: 10.1111/apha.12449] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
9 Kim T, Kim J, Park J, Lee J, Choi J, Kim H, Lee E, Kim S, Lee J, Kang H, Han P. Antidepressant effects of exercise are produced via suppression of hypocretin/orexin and melanin-concentrating hormone in the basolateral amygdala. Neurobiology of Disease 2015;79:59-69. [DOI: 10.1016/j.nbd.2015.04.004] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 6.0] [Reference Citation Analysis]
10 Heifetz A, Barker O, Morris GB, Law RJ, Slack M, Biggin PC. Toward an understanding of agonist binding to human Orexin-1 and Orexin-2 receptors with G-protein-coupled receptor modeling and site-directed mutagenesis. Biochemistry 2013;52:8246-60. [PMID: 24144388 DOI: 10.1021/bi401119m] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
11 Torterolo P, Scorza C, Lagos P, Urbanavicius J, Benedetto L, Pascovich C, López-Hill X, Chase MH, Monti JM. Melanin-Concentrating Hormone (MCH): Role in REM Sleep and Depression. Front Neurosci 2015;9:475. [PMID: 26733789 DOI: 10.3389/fnins.2015.00475] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 5.3] [Reference Citation Analysis]
12 Razavinia F, Tehranian N, Tatari FT, Bidhendi Yarandi R, Ramezani Tehrani F. The Postpartum Marital Satisfaction, Maternal Serum Concentration of Orexin-A and Mode of Delivery. J Sex Marital Ther 2019;45:488-96. [PMID: 30640582 DOI: 10.1080/0092623X.2019.1566947] [Reference Citation Analysis]
13 Lonstein JS, Linning‐duffy K, Tang Y, Moody A, Yan L. Impact of daytime light intensity on the central orexin (hypocretin) system of a diurnal rodent ( Arvicanthis niloticus ). Eur J Neurosci 2021;54:4167-81. [DOI: 10.1111/ejn.15248] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Fitch TE, Benvenga MJ, Jesudason CD, Zink C, Vandergriff AB, Menezes MM, Schober DA, Rorick-Kehn LM. LSN2424100: a novel, potent orexin-2 receptor antagonist with selectivity over orexin-1 receptors and activity in an animal model predictive of antidepressant-like efficacy. Front Neurosci 2014;8:5. [PMID: 24478625 DOI: 10.3389/fnins.2014.00005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
15 Moorman DE. The hypocretin/orexin system as a target for excessive motivation in alcohol use disorders. Psychopharmacology (Berl) 2018;235:1663-80. [PMID: 29508004 DOI: 10.1007/s00213-018-4871-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
16 Adidharma W, Deats SP, Ikeno T, Lipton JW, Lonstein JS, Yan L. Orexinergic modulation of serotonin neurons in the dorsal raphe of a diurnal rodent, Arvicanthis niloticus. Horm Behav 2019;116:104584. [PMID: 31445011 DOI: 10.1016/j.yhbeh.2019.104584] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
17 Caroleo M, Carbone EA, Primerano A, Foti D, Brunetti A, Segura-Garcia C. The role of hormonal, metabolic and inflammatory biomarkers on sleep and appetite in drug free patients with major depression: A systematic review. J Affect Disord 2019;250:249-59. [PMID: 30870775 DOI: 10.1016/j.jad.2019.03.015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 3.7] [Reference Citation Analysis]
18 Cho CH, Lee HJ, Woo HG, Choi JH, Greenwood TA, Kelsoe JR. CDH13 and HCRTR2 May Be Associated with Hypersomnia Symptom of Bipolar Depression: A Genome-Wide Functional Enrichment Pathway Analysis. Psychiatry Investig 2015;12:402-7. [PMID: 26207136 DOI: 10.4306/pi.2015.12.3.402] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
19 Arendt DH, Hassell J, Li H, Achua JK, Guarnieri DJ, Dileone RJ, Ronan PJ, Summers CH. Anxiolytic function of the orexin 2/hypocretin A receptor in the basolateral amygdala. Psychoneuroendocrinology 2014;40:17-26. [PMID: 24485472 DOI: 10.1016/j.psyneuen.2013.10.010] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 4.9] [Reference Citation Analysis]
20 Gabryelska A, Szmyd B, Maschauer EL, Roguski A, Canham R, Morrison I, Białasiewicz P, Riha RL. Utility of measuring CSF hypocretin-1 level in patients with suspected narcolepsy. Sleep Medicine 2020;71:48-51. [DOI: 10.1016/j.sleep.2020.03.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
21 Elbaz I, Levitas-Djerbi T, Appelbaum L. The Hypocretin/Orexin Neuronal Networks in Zebrafish. Curr Top Behav Neurosci 2017;33:75-92. [PMID: 28012092 DOI: 10.1007/7854_2016_59] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
22 Li SB, Jones JR, de Lecea L. Hypocretins, Neural Systems, Physiology, and Psychiatric Disorders. Curr Psychiatry Rep 2016;18:7. [PMID: 26733323 DOI: 10.1007/s11920-015-0639-0] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 5.5] [Reference Citation Analysis]
23 Melis C, Beauvais G, Muntean BS, Cirnaru MD, Otrimski G, Creus-Muncunill J, Martemyanov KA, Gonzalez-Alegre P, Ehrlich ME. Striatal Dopamine Induced ERK Phosphorylation Is Altered in Mouse Models of Monogenic Dystonia. Mov Disord 2021;36:1147-57. [PMID: 33458877 DOI: 10.1002/mds.28476] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Sirohi S, Van Cleef A, Davis JF. Binge-like intake of HFD attenuates alcohol intake in rats. Physiol Behav 2017;178:187-95. [PMID: 27765644 DOI: 10.1016/j.physbeh.2016.10.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
25 Murgatroyd CA, Peña CJ, Podda G, Nestler EJ, Nephew BC. Early life social stress induced changes in depression and anxiety associated neural pathways which are correlated with impaired maternal care. Neuropeptides 2015;52:103-11. [PMID: 26049556 DOI: 10.1016/j.npep.2015.05.002] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 5.7] [Reference Citation Analysis]
26 Murgatroyd CA, Taliefar M, Bradburn S, Carini LM, Babb JA, Nephew BC. Social stress during lactation, depressed maternal care, and neuropeptidergic gene expression. Behav Pharmacol 2015;26:642-53. [PMID: 26061353 DOI: 10.1097/FBP.0000000000000147] [Cited by in Crossref: 30] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
27 Tan JXM, Ang RJW, Wee CL. Larval Zebrafish as a Model for Mechanistic Discovery in Mental Health. Front Mol Neurosci 2022;15:900213. [DOI: 10.3389/fnmol.2022.900213] [Reference Citation Analysis]
28 Sutton EL. Psychiatric Disorders and Sleep Issues. Medical Clinics of North America 2014;98:1123-43. [DOI: 10.1016/j.mcna.2014.06.009] [Cited by in Crossref: 55] [Cited by in F6Publishing: 46] [Article Influence: 6.9] [Reference Citation Analysis]
29 Dimatelis JJ, Mtintsilana A, Naidoo V, Stein DJ, Russell VA. Chronic light exposure alters serotonergic and orexinergic systems in the rat brain and reverses maternal separation-induced increase in orexin receptors in the prefrontal cortex. Metab Brain Dis 2018;33:433-41. [DOI: 10.1007/s11011-017-0123-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
30 Yun S, Wennerholm M, Shelton JE, Bonaventure P, Letavic MA, Shireman BT, Lovenberg TW, Dugovic C. Selective Inhibition of Orexin-2 Receptors Prevents Stress-Induced ACTH Release in Mice. Front Behav Neurosci 2017;11:83. [PMID: 28533747 DOI: 10.3389/fnbeh.2017.00083] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
31 Swaab DF, Bao A. Sex differences in stress-related disorders: Major depressive disorder, bipolar disorder, and posttraumatic stress disorder. Sex Differences in Neurology and Psychiatry. Elsevier; 2020. pp. 335-58. [DOI: 10.1016/b978-0-444-64123-6.00023-0] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
32 Shariq AS, Rosenblat JD, Alageel A, Mansur RB, Rong C, Ho RC, Ragguett R, Pan Z, Brietzke E, Mcintyre RS. Evaluating the role of orexins in the pathophysiology and treatment of depression: A comprehensive review. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2019;92:1-7. [DOI: 10.1016/j.pnpbp.2018.12.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 4.7] [Reference Citation Analysis]
33 Ozsoy S, Olguner Eker O, Abdulrezzak U, Esel E. Relationship between orexin A and childhood maltreatment in female patients with depression and anxiety. Social Neuroscience 2016;12:330-6. [DOI: 10.1080/17470919.2016.1169216] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
34 Savitz A, Wajs E, Zhang Y, Xu H, Etropolski M, Thase ME, Drevets W. Efficacy and safety of seltorexant as adjunctive therapy in major depressive disorder: A phase 2b, randomized, placebo-controlled, adaptive dose-finding study. Int J Neuropsychopharmacol 2021:pyab050. [PMID: 34324636 DOI: 10.1093/ijnp/pyab050] [Reference Citation Analysis]
35 Howland RH. Suvorexant: a novel therapy for the treatment of insomnia. J Psychosoc Nurs Ment Health Serv 2014;52:23-6. [PMID: 25291725 DOI: 10.3928/02793695-20140924-01] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
36 Calegare BF, Costa A, Fernandes L, Dias AL, Torterolo P, Almeida VD. Subchronical treatment with Fluoxetine modifies the activity of the MCHergic and hypocretinergic systems. Evidences from peptide CSF concentration and gene expression. Sleep Sci 2016;9:89-93. [PMID: 27656272 DOI: 10.1016/j.slsci.2016.05.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
37 Dale E, Bang-andersen B, Sánchez C. Emerging mechanisms and treatments for depression beyond SSRIs and SNRIs. Biochemical Pharmacology 2015;95:81-97. [DOI: 10.1016/j.bcp.2015.03.011] [Cited by in Crossref: 123] [Cited by in F6Publishing: 113] [Article Influence: 17.6] [Reference Citation Analysis]
38 Clifford L, Dampney BW, Carrive P. Spontaneously hypertensive rats have more orexin neurons in their medial hypothalamus than normotensive rats. Exp Physiol 2015;100:388-98. [PMID: 25640802 DOI: 10.1113/expphysiol.2014.084137] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 4.4] [Reference Citation Analysis]
39 Subramanian S, Ravichandran M. Orexin receptors: Targets and applications. Fundam Clin Pharmacol 2021. [PMID: 34464995 DOI: 10.1111/fcp.12723] [Reference Citation Analysis]
40 Jalewa J, Wong-lin K, Mcginnity TM, Prasad G, Hölscher C. Increased number of orexin/hypocretin neurons with high and prolonged external stress-induced depression. Behavioural Brain Research 2014;272:196-204. [DOI: 10.1016/j.bbr.2014.05.030] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 5.1] [Reference Citation Analysis]
41 Ketchesin KD, Becker-Krail D, McClung CA. Mood-related central and peripheral clocks. Eur J Neurosci 2020;51:326-45. [PMID: 30402924 DOI: 10.1111/ejn.14253] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
42 Park YK, Kwon O, Joo EY, Kim J, Lee JM, Kim ST, Hong SB. White matter alterations in narcolepsy patients with cataplexy: tract-based spatial statistics. J Sleep Res 2016;25:181-9. [DOI: 10.1111/jsr.12366] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
43 Kuwano N, Kato TA, Mitsuhashi M, Sato-Kasai M, Shimokawa N, Hayakawa K, Ohgidani M, Sagata N, Kubo H, Sakurai T, Kanba S. Neuron-related blood inflammatory markers as an objective evaluation tool for major depressive disorder: An exploratory pilot case-control study. J Affect Disord 2018;240:88-98. [PMID: 30059939 DOI: 10.1016/j.jad.2018.07.040] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
44 Petrous J, Furmaga K. Adverse reaction with suvorexant for insomnia: acute worsening of depression with emergence of suicidal thoughts. BMJ Case Rep 2017;2017:bcr-2017-222037. [PMID: 29066641 DOI: 10.1136/bcr-2017-222037] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
45 Herring WJ, Roth T, Krystal AD, Michelson D. Orexin receptor antagonists for the treatment of insomnia and potential treatment of other neuropsychiatric indications. J Sleep Res 2018;28. [DOI: 10.1111/jsr.12782] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
46 Barandas R, Landgraf D, Mccarthy MJ, Welsh DK. Circadian Clocks as Modulators of Metabolic Comorbidity in Psychiatric Disorders. Curr Psychiatry Rep 2015;17. [DOI: 10.1007/s11920-015-0637-2] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 6.0] [Reference Citation Analysis]
47 Brietzke E, Vazquez GH, Kang MJY, Soares CN. Pharmacological treatment for insomnia in patients with major depressive disorder. Expert Opin Pharmacother 2019;20:1341-9. [PMID: 31046480 DOI: 10.1080/14656566.2019.1614562] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]